S. Pascoe

Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study

Martin J. van den Bent, Brigitta G. Baumert, Sara Erridge et al. · The Lancet · 2017 · 392 citations · Full text

Catnon Trial, Treatment Strategies, Radiation Therapy +13

A Randomized, Double-Blind, Dose-Finding, Multicenter, Phase 2 Study of Radium Chloride (Ra 223) in Patients with Bone Metastases and Castration-Resistant Prostate Cancer

Christopher Parker, S. Pascoe, Aleš Chodacki et al. · European Urology · 2012 · 183 citations

Ra 223, Radiation Medicine, Urology +7

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

Chris Parker, Noel W. Clarke, Adrian Cook et al. · The Lancet · 2024 · 43 citations · Full text

Paraneoplastic subacute sensory neuronopathy in association with adenocarcinoma of the prostate

S. Pascoe · BMJ Case Reports · 2011 · 11 citations · Full text

Neuro-oncology, Endocrine Oncology, Urology +11